Bergithe Eikeland Oftedals bilde

Bergithe Eikeland Oftedal

  • E-postBergithe.Oftedal@uib.no
  • Telefon+47 976 89 880
  • Besøksadresse
    Haukeland universitetssykehus, Laboratoriebygget
  • Postadresse
    Postboks 7804
    5020 Bergen

Post doc i gruppen Endokrin medisin ledet av Professor Eystein Husebye. Forsker på endokrin autoimmunitet, med spesielt fokus på den monogene autoimmune sykdommen autoimmun polyendokrin svikt type I (APS-I) og genet som forårsaker denne sykdommen, autoimmun regulator (AIRE) genet.

Vitenskapelig artikkel
  • Vis forfatter(e) 2021. Transcriptional changes in regulatory T cells from patients with autoimmune polyendocrine syndrome type 1 suggest functional impairment of lipid metabolism and gut homing. Frontiers in Immunology.
  • Vis forfatter(e) 2021. GWAS for autoimmune Addison's disease identifies multiple risk loci and highlights AIRE in disease susceptibility. Nature Communications. 959.
  • Vis forfatter(e) 2019. Identification and characterization of rare Toll-like receptor 3 variants in patients with autoimmune Addison’s disease. Journal of translational autoimmunity.
  • Vis forfatter(e) 2019. Coexistence of congenital adrenal hyperplasia and autoimmune Addison's disease. Frontiers in Endocrinology. 1-5.
  • Vis forfatter(e) 2018. Oral microbiota in autoimmune polyendocrine syndrome type 1. Journal of Oral Microbiology. 1-10.
  • Vis forfatter(e) 2018. 21-hydroxylase autoantibodies are more prevalent in Turner syndrome but without an association to the autoimmune polyendocrine syndrome type I. Clinical and Experimental Immunology. 1-5.
  • Vis forfatter(e) 2017. T cell receptor assessment in autoimmune disease requires access to the most adjacent immunologically active organ. Journal of Autoimmunity. 24-33.
  • Vis forfatter(e) 2017. Impaired salivary gland activity in patients with autoimmune polyendocrine syndrome type I. Autoimmunity. 211-222.
  • Vis forfatter(e) 2017. Expanding the Phenotypic and Genotypic Landscape of Autoimmune Polyendocrine Syndrome Type 1. Journal of Pediatric Endocrinology & Metabolism (JPEM). 3546-3556.
  • Vis forfatter(e) 2017. Altered immune activation and IL-23 signaling in response to Candida albicans in autoimmune polyendocrine syndrome type 1. Frontiers in Immunology. 1-10.
  • Vis forfatter(e) 2016. A variant in the BACH2 gene is associated with susceptibility to autoimmune addison's disease in humans. Journal of Clinical Endocrinology and Metabolism. 3865-3869.
  • Vis forfatter(e) 2016. A longitudinal follow-up of autoimmune polyendocrine syndrome type 1. Journal of Clinical Endocrinology and Metabolism. 2975-2983.
  • Vis forfatter(e) 2015. Revealing missing human protein isoforms based on Ab initio prediction, RNA-seq and proteomics. Scientific Reports.
  • Vis forfatter(e) 2015. Dominant mutations in the autoimmune regulator AIRE are associated with common organ-specific autoimmune diseases. Immunity. 1185-1196.
  • Vis forfatter(e) 2015. 8q13.1-q13.2 deletion associated with inferior cerebellar vermian hypoplasia and digital anomalies: A new syndrome? Pediatric Neurology. 230-234.e1.
  • Vis forfatter(e) 2014. Clinical and serologic parallels to APS-I in patients with thymomas and autoantigen transcripts in their tumors. Journal of Immunology. 3880-3890.
  • Vis forfatter(e) 2014. ARMC5 mutations are common in familial bilateral macronodular adrenal hyperplasia. Journal of Clinical Endocrinology and Metabolism. E1784-E1792.
  • Vis forfatter(e) 2014. A novel cell-based assay for measuring neutralizing autoantibodies against type I interferons in patients with autoimmune polyendocrine syndrome type 1. Clinical Immunology. 220-227.
  • Vis forfatter(e) 2013. Anti-cytokine autoantibodies preceding onset of autoimmune polyendocrine syndrome type I features in early childhood. Journal of Clinical Immunology. 1341-1348.
  • Vis forfatter(e) 2012. Radioligand-binding assay reveals distinct autoantibody preferences for type I interferons in APS I and myasthenia gravis subgroups. Journal of Clinical Immunology. 230-237.
  • Vis forfatter(e) 2011. Measuring autoantibodies against IL-17F and IL-22 in Autoimmune Polyendocrine Syndrome Type I by radioligand binding assay using fusion proteins. Scandinavian Journal of Immunology. 327-333.
  • Vis forfatter(e) 2010. Flow cytometry study of blood cell subtypes reflects autoimmune and inflammatory processes in autoimmune polyendocrine syndrome type I. Scandinavian Journal of Immunology. 459-467.
  • Vis forfatter(e) 2008. Radioimmunoassay for autoantibodies against interferon omega; its use in the diagnosis of autoimmune polyendocrine syndrome type I. Clinical Immunology. 163-169.
  • Vis forfatter(e) 2008. AIRE variations in Addison's disease and autoimmune polyendocrine syndromes (APS): partial gene deletions contribute to APS I. Genes and Immunity. 130-136.
  • Vis forfatter(e) 2005. Ligand-dependent protein interactions of the estrogen receptors using the yeast two-hybrid system. Annals of the New York Academy of Sciences. 420-425.
  • Vis forfatter(e) 2005. Exploring protein-protein interactions between ligand activated transcription factors using the yeast two-hybrid system.
  • Vis forfatter(e) 2019. Exploring and redefining Autoimmune polyendocrine syndrome type 1.
  • Vis forfatter(e) 2012. Autoimmune polyendocrine syndrome type I –novel diagnostic assays and immune regulation.
Vitenskapelig Kapittel/Artikkel/Konferanseartikkel
  • Vis forfatter(e) 2019. The Natural History of APS1. 7 sider.
  • Vis forfatter(e) 2019. Aire Mutations and Autoimmune Diseases. 24 sider.
  • Vis forfatter(e) 2013. Dominant Inheritance in Autoimmune Endocrine Syndrome Type 1. Scandinavian Journal of Immunology. 306-307.
  • Vis forfatter(e) 2012. Deviant expression of defensins in sera and saliva of patients with autoimmune polyendocrine syndrome type I. Immunology. 211-212.
  • Vis forfatter(e) 2010. Nucleoporin 62, a Novel Autoantigen in Patients with Autoimmune Polyendocrine Syndrome Type I (APS I). Scandinavian Journal of Immunology. 493-494.
  • Vis forfatter(e) 2013. A novel cell-based assay for measuring neutralizing autoantibodies against type I interferons in patients with APS-1.
Vitenskapelig oversiktsartikkel/review
  • Vis forfatter(e) 2020. The prospects of single-cell analysis in autoimmunity. Scandinavian Journal of Immunology. 1-15.
  • Vis forfatter(e) 2020. New ERA of therapy for endocrine autoimmune disorders. Scandinavian Journal of Immunology. 1-23.
  • Vis forfatter(e) 2016. AIRE-mutations and autoimmune disease. Current Opinion in Immunology. 8-15.

Se fullstendig oversikt over publikasjoner i CRIStin.

Immunologi, autoimmunitet, genetikk, immuncellerepertoar, autoantistoff

Normal 0 false false false EN-GB X-NONE X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin:0cm; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Calibri","sans-serif"; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-fareast-language:EN-US;}